Lexology - Pearce IP https://www.lexology.com Lexology daily feed Law Business Research 2006 - 2025 en-us admin@lexology.com (Lexology) https://www.lexology.com/images/logo.gif Lexology - Pearce IP https://www.lexology.com Saturday Sunday Access Denied - Federal Court Finds Apple Did Not Infringe Biometric Security Patents Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=900b996f-9aac-458e-a36c-0321c4fa3eaa https://www.lexology.com/library/detail.aspx?g=900b996f-9aac-458e-a36c-0321c4fa3eaa Tue, 23 Dec 2025 00:00:00 GMT Australia Litigation Patents Aristocrat Hits the Jackpot - Full Court Resurrects Computer-Implemented Inventions from the Patent Graveyard Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=7651fe2c-c1d3-4db3-a928-589c77dd2269 https://www.lexology.com/library/detail.aspx?g=7651fe2c-c1d3-4db3-a928-589c77dd2269 Mon, 22 Dec 2025 00:00:00 GMT Australia Litigation Patents Alvotech/Advanz First to Launch Golimumab Biosimilar Worldwide Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=c1794f38-e71b-4dd9-ab1b-799e07de1474 https://www.lexology.com/library/detail.aspx?g=c1794f38-e71b-4dd9-ab1b-799e07de1474 Mon, 22 Dec 2025 00:00:00 GMT European Union United Kingdom Healthcare & Life Sciences Alvotech/Teva’s Biosimilar Aflibercept Set for Q4/26 US Launch Following Regeneron Settlement & Licence Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=b90948be-5dc3-48d0-bfda-0d0f27d3a9f2 https://www.lexology.com/library/detail.aspx?g=b90948be-5dc3-48d0-bfda-0d0f27d3a9f2 Fri, 19 Dec 2025 00:00:00 GMT USA Healthcare & Life Sciences Litigation FDA approves Ph I Trial of Shanghai Henlius’ Biosimilar Nivolumab Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=07f3d386-0906-4d22-bbf1-15041c0b3bbc https://www.lexology.com/library/detail.aspx?g=07f3d386-0906-4d22-bbf1-15041c0b3bbc Fri, 19 Dec 2025 00:00:00 GMT USA Healthcare & Life Sciences Positive CHMP Opinion for Celltrion’s Biosimilar Ustekinumab Autoinjector Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=0c70b55c-3f39-4c9b-a35c-0c364f5820f1 https://www.lexology.com/library/detail.aspx?g=0c70b55c-3f39-4c9b-a35c-0c364f5820f1 Thu, 18 Dec 2025 00:00:00 GMT European Union Healthcare & Life Sciences Celltrion’s Aflibercept, Denosumab and Tocilizumab Biosimilars Recommended for PBS-Listing Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=05c341aa-c29a-4a2d-b8bb-4494912c6e2c https://www.lexology.com/library/detail.aspx?g=05c341aa-c29a-4a2d-b8bb-4494912c6e2c Thu, 18 Dec 2025 00:00:00 GMT Australia Healthcare & Life Sciences Patents Swiss-style Patent Claims In New Zealand - Part 3 Infringement Considerations Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=731a3d20-f7ac-4f8c-aba2-5f2b7b066526 https://www.lexology.com/library/detail.aspx?g=731a3d20-f7ac-4f8c-aba2-5f2b7b066526 Thu, 18 Dec 2025 00:00:00 GMT New Zealand Litigation Patents PiPCast™ | IP Protection for Three-Dimensional Shapes in New Zealand Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=d603ca84-d6c0-411c-b713-0786467c4d32 https://www.lexology.com/library/detail.aspx?g=d603ca84-d6c0-411c-b713-0786467c4d32 Thu, 18 Dec 2025 00:00:00 GMT New Zealand Copyrights Designs and trade secrets Patents Trademarks Reimbursement Recommendation in Canada for Opdivo® plus Yervoy® for MSI-H/dMMR Metastatic Colorectal Cancer Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=a107aef7-b19c-48c2-b0bf-5ffe22090fa6 https://www.lexology.com/library/detail.aspx?g=a107aef7-b19c-48c2-b0bf-5ffe22090fa6 Wed, 17 Dec 2025 00:00:00 GMT Canada Healthcare & Life Sciences Federal Court of Australia Awards Janssen First Pharmaceutical Patent Preliminary Injunction in 7 Years Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=ee9969ed-9092-434f-9c5e-55f25aadf6db https://www.lexology.com/library/detail.aspx?g=ee9969ed-9092-434f-9c5e-55f25aadf6db Wed, 17 Dec 2025 00:00:00 GMT Australia Healthcare & Life Sciences Litigation Patents Celltrion’s Biosimilar Ustekinumab Pre-Filled Pen Approved in Australia Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=342eb7a4-049e-4242-ae1a-f629b53b422b https://www.lexology.com/library/detail.aspx?g=342eb7a4-049e-4242-ae1a-f629b53b422b Tue, 16 Dec 2025 00:00:00 GMT Australia Healthcare & Life Sciences Will a “Skinny Label” Avoid Pharmaceutical Patent Infringement in Australia and New Zealand Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=da6d5b56-a76a-469a-930d-2d85c65936e5 https://www.lexology.com/library/detail.aspx?g=da6d5b56-a76a-469a-930d-2d85c65936e5 Tue, 16 Dec 2025 00:00:00 GMT Australia New Zealand Litigation Patents Celltrion Launches Biosimilar Aflibercept in EU & UK Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=c382d530-87ef-4ba6-9def-6fab619a0fde https://www.lexology.com/library/detail.aspx?g=c382d530-87ef-4ba6-9def-6fab619a0fde Tue, 16 Dec 2025 00:00:00 GMT European Union United Kingdom Healthcare & Life Sciences Litigation Patents Mabwell Launches Biosimilar Denosumab Outside China Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=649332c8-8e89-46ea-a8ee-f4d8f8be56f8 https://www.lexology.com/library/detail.aspx?g=649332c8-8e89-46ea-a8ee-f4d8f8be56f8 Tue, 16 Dec 2025 00:00:00 GMT Australia China Healthcare & Life Sciences New Indication Alert: FDA Approves Perjeta® Plus Enhertu® for HER2-Postive Breast Cancer Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=8ae6338b-83a3-454c-930d-20a5dfb33f8b https://www.lexology.com/library/detail.aspx?g=8ae6338b-83a3-454c-930d-20a5dfb33f8b Mon, 15 Dec 2025 00:00:00 GMT USA Healthcare & Life Sciences Swiss-style Patent Claims In New Zealand - Part 2 Law and Policy Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=a186e421-52bc-4b27-a473-9d12545ef6b8 https://www.lexology.com/library/detail.aspx?g=a186e421-52bc-4b27-a473-9d12545ef6b8 Mon, 15 Dec 2025 00:00:00 GMT New Zealand Litigation Patents Biocon Secures UK/EU/ROW Settlement with Regeneron/Bayer for Biosimilar Aflibercept; UK Launch in Jan 2026 Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=16bf48b4-f6d1-437b-a6df-4f29c43e8758 https://www.lexology.com/library/detail.aspx?g=16bf48b4-f6d1-437b-a6df-4f29c43e8758 Sat, 13 Dec 2025 00:00:00 GMT European Union United Kingdom Healthcare & Life Sciences Litigation Patents Positive CHMP Opinions for Bio-Thera/STADA’s Golimumab & Lupin’s Ranibizumab Biosimilars Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=6eba638a-e666-49b3-971e-7d9c9c88bc3d https://www.lexology.com/library/detail.aspx?g=6eba638a-e666-49b3-971e-7d9c9c88bc3d Fri, 12 Dec 2025 00:00:00 GMT European Union Healthcare & Life Sciences Celltrion Signs Listing Agreement with Major US PBM for Biosimilar Tocilizumab Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=c722ff06-0ede-4263-a497-a35052cc7317 https://www.lexology.com/library/detail.aspx?g=c722ff06-0ede-4263-a497-a35052cc7317 Fri, 12 Dec 2025 00:00:00 GMT USA Healthcare & Life Sciences High Court Draws Clear Line Between Trade Mark Infringement and Misleading and Deceptive Conduct in Bed Bath N’ Table Case Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=b3c27075-1470-4138-8da7-660174a7fa18 https://www.lexology.com/library/detail.aspx?g=b3c27075-1470-4138-8da7-660174a7fa18 Fri, 12 Dec 2025 00:00:00 GMT Australia Litigation Trademarks CHMP Recommends Indication Extensions for Regeneron/Bayer’s Eylea® 8mg & Janssen’s Simponi® Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=2ad85ce2-7ede-4267-9046-936b1716e262 https://www.lexology.com/library/detail.aspx?g=2ad85ce2-7ede-4267-9046-936b1716e262 Fri, 12 Dec 2025 00:00:00 GMT European Union Healthcare & Life Sciences FDA Grants Priority Review to BMS’ sBLA for Opdivo® Plus Chemo for Classical Hodgkin Lymphoma Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=7c246ee9-b757-4777-a1ca-181be17430ed https://www.lexology.com/library/detail.aspx?g=7c246ee9-b757-4777-a1ca-181be17430ed Thu, 11 Dec 2025 00:00:00 GMT USA Healthcare & Life Sciences Zydus Launches Biosimilar Denosumab in India Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=cbb25685-db0b-4420-b908-b3f9247efa57 https://www.lexology.com/library/detail.aspx?g=cbb25685-db0b-4420-b908-b3f9247efa57 Wed, 10 Dec 2025 00:00:00 GMT India Healthcare & Life Sciences Polpharma & Libbs Farmacêutica Partner on Autoimmune Disease Biosimilar in Brazil Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=42dde6fa-61aa-4fb9-84d0-40def63a5a22 https://www.lexology.com/library/detail.aspx?g=42dde6fa-61aa-4fb9-84d0-40def63a5a22 Wed, 10 Dec 2025 00:00:00 GMT Brazil Healthcare & Life Sciences Swiss-style Patent Claims In New Zealand - Part 1 History and background Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=d1c23d2a-2448-403d-ac9d-bac81e5540ee https://www.lexology.com/library/detail.aspx?g=d1c23d2a-2448-403d-ac9d-bac81e5540ee Tue, 09 Dec 2025 00:00:00 GMT New Zealand Litigation Patents The End of an Era for Pharma PTEs in AU - Full Court Excludes Formulation Patent Term Extensions in Aripiprazole (ABILIFY) Appeal Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=ae637bce-c1fd-4976-a5ce-828d1cebb490 https://www.lexology.com/library/detail.aspx?g=ae637bce-c1fd-4976-a5ce-828d1cebb490 Tue, 09 Dec 2025 00:00:00 GMT Australia Litigation Patents Formycon & Zydus Ink Exclusive Deal for Biosimilar Pembrolizumab in US & Canada Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=8c1f7977-1a2e-400d-b71b-09e37868fceb https://www.lexology.com/library/detail.aspx?g=8c1f7977-1a2e-400d-b71b-09e37868fceb Tue, 09 Dec 2025 00:00:00 GMT Canada USA Healthcare & Life Sciences Binnopharm & Mabwell Partner on Biosimilar Dupilumab in Russia Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=387fedbc-fb29-450c-adc6-efac4fe483ab https://www.lexology.com/library/detail.aspx?g=387fedbc-fb29-450c-adc6-efac4fe483ab Mon, 08 Dec 2025 00:00:00 GMT Australia Russia Healthcare & Life Sciences Celltrion to Expand Use of SC Formulation Technology Including to Develop SC Trastuzumab Biosimilar Pearce IP ...... https://www.lexology.com/library/detail.aspx?g=24c05363-5016-45f9-952d-377555dd0197 https://www.lexology.com/library/detail.aspx?g=24c05363-5016-45f9-952d-377555dd0197 Mon, 08 Dec 2025 00:00:00 GMT Australia Healthcare & Life Sciences